Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Investors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $5 Put had some of the highest implied...

PBYI : 3.00 (-0.33%)
Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Investors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $5 Put had some of the highest implied...

PBYI : 3.00 (-0.33%)
PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates

Puma Biotechnology PBYI reported fourth-quarter 2024 adjusted earnings of 43 cents per share, which beat the Zacks Consensus Estimate of 14 cents. In the year-ago quarter, the company reported adjusted...

FOLD : 7.35 (+2.08%)
IMCR : 30.16 (-0.66%)
PBYI : 3.00 (-0.33%)
PCRX : 25.72 (-1.08%)
Puma Biotech: Q4 Earnings Snapshot

Puma Biotech: Q4 Earnings Snapshot

PBYI : 3.00 (-0.33%)
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational pipeline candidates, VIR-5818 and VIR-5500, for the treatment of various solid tumors.While...

CTMX : 0.7100 (-7.29%)
PBYI : 3.00 (-0.33%)
CSTL : 20.63 (-1.43%)
VIR : 6.12 (-2.70%)
CorMedix Stock Rises on Q4 Preliminary Sales Beating Estimates

Shares of CorMedix CRMD rose nearly 30% on Tuesday after management announced fourth-quarter and full-year 2024 preliminary sales figures.CorMedix’s Preliminary Sales Figures Beat EstimatesCorMedix reported...

CTMX : 0.7100 (-7.29%)
PBYI : 3.00 (-0.33%)
CSTL : 20.63 (-1.43%)
CRMD : 9.10 (-0.55%)
Geron Stock Rallies More Than 60% in a Year: Here's Why

For Geron Corporation GERN, 2024 was a transformational year as it saw the FDA approval and commercial launch of Rytelo (imetelstat) for the treatment of low- to intermediate-1 risk myelodysplastic syndromes...

PBYI : 3.00 (-0.33%)
CSTL : 20.63 (-1.43%)
GERN : 1.4200 (unch)
HALO : 60.49 (+2.09%)
Here's Why You Should Consider Buying Atara Biotherapeutics Stock

Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a...

PBYI : 3.00 (-0.33%)
CSTL : 20.63 (-1.43%)
ATRA : 7.32 (-3.68%)
HALO : 60.49 (+2.09%)
Best Momentum Stocks to Buy for January 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6:NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has a Zacks Rank #1 and...

PDEX : 64.89 (-3.03%)
PBYI : 3.00 (-0.33%)
NRXP : 2.07 (unch)
Best Value Stocks to Buy for January 6th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 6:Ashford Hospitality Trust, Inc. AHT: This real estate investment trust carries a Zacks Rank...

CWD : 0.2490 (+0.81%)
PBYI : 3.00 (-0.33%)
AHT : 6.08 (-4.70%)

Barchart Exclusives

2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing
Two checkered names from diverse industries are looking to bolster their manufacturing capabilities in the U.S. Here's how they stack up as investment ideas. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar